Main event on health industry Oslo Life Science 2019

We highlighted inspiring examples on collaboration between academia and industry that have benefitted patients and society. How can we learn from these examples while building the health industry in Oslo and Norway?

Time and place: – , The University Aula

Pictures and videos from the event

Swipe on the arrows on the pictures in the image carousel below. Links to videos in the caption for each picture. 

Error: resource not found: /english/research/strategic-research-areas/life-science/oslo-life-science-conference/oslo-life-science-2019/pictures/main-event

Programme

The event consisted of three parts: 1) inspiring examples on collaboration between academia and industry that have benefitted patients and society, 2) the journey from academia to industry with pitches from entrepreneurs, and 3) presentation and debate on the new white paper on health industry. 

Target groups: researchers, students, bureaucrats, businesspeople, investors and politicians. 

12.30 Session 1: 
Welcome and inspiring examples on collaboration between academia

Welcome – the latest news on the life science building at UiO and its role for science and health industry

Svein St?len, Rector, UiO

Chair

Andrea Winkler, Professor and Director of Centre for Global Health, the Faculty of Medicine, UiO

Opening speech by Bayer – the company that bought Algeta, the number one life science success story of the University of Oslo

Kemal Malik, Board of Management of Bayer AG responsible for innovation

FinnGen – a unique collaboration between academia and industry to find the next breakthroughs in disease prevention, diagnosis and treatment
Aarno Palotie, Research Director, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki; Faculty member, Center for Human Genome Research at the Massachusetts General Hospital; Associate member, Broad Institute of MIT and Harvard

Innovation and industry collaboration in translational research – lessons learned from Finnish FIMM to inspire the Norwegian NCMM and the life science community in Oslo

Janna Saarela, the new Director of the Centre for Molecular Medicine Norway (NCMM), UiO, who comes from Institute for Molecular Medicine Finland (FIMM)

Nt-proBNP – the biomarker for heart failure that conquered the world from Oslo

Professor II Christian Hall, University of Oslo and Vestre Viken Hospital Trust; and Mathias Egermark, MD, Senior Vice President, Life Cycle Leader Cardiac, Women's Health & Personalised Healthcare Solutions, Roche Diagnostics International

Cutting edge technology for the benefit of patients and society from successful collaboration between the intervention centre at Oslo University Hospital and Siemens

Anne Figel, Director Global Marketing Neurosurgery, Trauma and Orthopedics at Siemens Healthineers

14.10 Break with refreshments

14.50 Session 2: 
The journey from academia to industry – pitches from entrepreneurs
 

Projects in UiO:Life Science's innovation programme for health related life sciences SPARK Norway, Oslo Cancer Cluster and Norway Health Tech. 

Moderator for pitching session: Jutta Heix, Oslo Cancer Cluster

  • Johanna Olweus, Professor, UiO/OUS
  • Maria Vistnes, Postdoc, UiO and team leader SPARK Norway project
  • Gjermund Henriksen, Professor II, and team leader SPARK Norway project
  • Simone Mester, PhD student, UiO/OUS and team leader SPARK Norway project
  • Jean-Luc Boulland, Researcher, Norwegian Center for Stem Cell Research, UiO/OUS and team leader SPARK Norway project
  • Claudia Alejandra McDonald B?en, PhD, CEO, Arctic Pharma AS
  • Shane West, CEO Cardiaccs
  • Dag Christiansen, CEO Cardinor
  • Panel: Morten Egeberg, UiO:Life Science, Daniel Malarek, Roche, and Rannveig Fadum, Innovation Norway

15.55 Session 3: 
Presentation and debate on the new white paper on health industry

The new white paper on health industry

Presented by Bent H?ie, Minister of Health
 

Debate on lessons learned from the examples we’ve heard – and a new era with the new white paper on health industry

Moderator for the debate: Markus Moe, Editor-in-chief, Dagens Medisin

  • Bent H?ie, Minister of Health
  • Ingvild Kjerkol, Labour Party Member of the Storting 
  • Per Morten Sandset, Vice-Rector Research and Innovation, UiO
  • Kathrine Myhre, CEO, Norway Health Tech
  • Ketil Widerberg, General Manager, Oslo Cancer Cluster

Closing remarks

Carl Henrik G?rbitz, Director, UiO:Life Science

Reception for all conference attendees right after the main event.

Organizer

UiO:Life Science, Oslo Cancer Cluster, Norway Health Tech, LMI and Sponsor: The Research Council of Norway
Published Nov. 19, 2018 4:24 PM - Last modified Feb. 2, 2023 5:48 PM
E-mail this page